Related Experiment Video
Updated: Aug 19, 2025

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Cerebral Sinovenous Thrombosis in Infants and Children: A Practical Approach to Management
Noa Mandel-Shorer1, Christine A Sabapathy2, Pradeep Krishnan3
1Department of Pediatric Hematology-Oncology, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel.
Insights
Cerebral sinovenous thrombosis (CSVT) in children is serious but treatable. This review discusses ongoing debates and uncertainties in anticoagulation therapy for pediatric CSVT, highlighting the need for evidence-based guidelines.
Area of Science:
- Neurology
- Hematology
- Pediatrics
Background:
- Cerebral sinovenous thrombosis (CSVT) is a rare but severe condition in children, potentially causing significant neurological issues.
- Current guidelines recommend early diagnosis and anticoagulation for pediatric CSVT.
- However, a lack of clinical trials leads to uncertainties in treatment protocols.
Approach:
- This review examines common challenges and controversies in pediatric CSVT anticoagulation.
- It focuses on issues debated by pediatric neurologists and hematologists.
- The review synthesizes current understanding and identifies areas needing further research.
Key Points:
- Evidence-based selection criteria for anticoagulation in pediatric CSVT are lacking.
- Optimal anticoagulant choice, monitoring, and treatment duration remain debated.
- Consensus guidelines highlight the need for prompt anticoagulation but lack trial support.
Conclusions:
- Significant uncertainties persist regarding anticoagulation practices for pediatric CSVT.
- Further clinical trials are essential to establish evidence-based treatment protocols.
- Addressing these debates is crucial for optimizing pediatric CSVT management.
Abstract:
Cerebral sinovenous thrombosis (CSVT) is a rare, yet potentially devastating disorder, associated with acute complications and long-term neurologic sequelae. Consensus-based international pediatric CSVT treatment guidelines emphasize early clinical-radiologic recognition and prompt consideration for anticoagulation therapy. However, lack of clinical trials has precluded evidence-based patient selection, anticoagulant choice, optimal monitoring parameters and treatment duration. Consequently, uncertainties and controversies persist regarding anticoagulation practices in pediatric CSVT. This review focuses on commonly encountered issues that continue to pose questions and raise debates regarding anticoagulation therapy among pediatric neurologists and hematologists.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Aneurysm IV: Nursing Management

